Company Description
People may call childbirth the miracle of life, but Bayer Schering Pharma would rather help you avoid it. The global ethical pharmaceuticals unit of...
Key Bayer Schering Pharma Financials
| Company Type | Public - Pink Sheets: SHRGY; German: SCH Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2005 Employees | 25,037 |
More Bayer Schering Pharma Financials (9 pages)
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Bayer Schering Pharma's competition across multiple industries
Top Bayer Schering Pharma Competitors
Sponsored Links
The Business Directory
Bayer Schering Pharma Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman of the Supervisory Board | Werner Wenning | Network | E-mail |
| Chairman of the Executive Board | Arthur J. Higgins | Network | E-mail |
| Member of the Executive Board, Administration, Organization, Human Resources, and Production | Werner Baumann | Network | E-mail |
More Bayer Schering Pharma Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Bayer Schering Pharma News
- Strike closes five Norwegian airports [UPI Business News] (16 May 2008 00:01:00 EDT)
- Norway plans tents for refugees [UPI Top Stories] (16 May 2008 00:01:00 EDT)
- Norwegian media group Schibsted ASA acquires Belgian online classified site Kapaza.be [Nordic Business Report] (16 May 2008 00:01:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.